327 results on '"Bale, Tejus"'
Search Results
2. ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors
3. Development and prospective validation of an artificial intelligence-based smartphone app for rapid intraoperative pituitary adenoma identification
4. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors
5. Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrence
6. Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain
7. CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas
8. Expanding the Molecular Diversity of CIC-Rearranged Sarcomas With Novel and Very Rare Partners
9. Radiomic Analysis to Predict Histopathologically Confirmed Pseudoprogression in Glioblastoma Patients
10. Comprehensive genomic profiling of EWSR1/FUS::CREB translocation-associated tumors uncovers prognostically significant recurrent genetic alterations and methylation-transcriptional correlates
11. Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells
12. Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy
13. YAP1-MAML2 fusion in a pediatric NF2-wildtype intraparenchymal brainstem schwannoma
14. DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival
15. Characterization, isolation, and in vitro culture of leptomeningeal fibroblasts
16. Salvage resection of recurrent previously irradiated brain metastases: tumor control and radiation necrosis dependency on adjuvant re-irradiation
17. Clinical Experience of Cerebrospinal Fluid–Based Liquid Biopsy Demonstrates Superiority of Cell-Free DNA over Cell Pellet Genomic DNA for Molecular Profiling
18. A Pan-Cancer Study of Somatic TERT Promoter Mutations and Amplification in 30,773 Tumors Profiled by Clinical Genomic Sequencing
19. Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression
20. Expanding the clinicopathologic spectrum and genomic landscape of tumors with SMARCA2/4::CREM fusions.
21. Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions.
22. Molecular epidemiology of IDH2 hotspot mutations in cancer and immunohistochemical detection of R172K, R172G, and R172M variants
23. Validation of a digital pathology system including remote review during the COVID-19 pandemic
24. Cell Lineage-Based Stratification for Glioblastoma
25. Infarction with associated pseudosarcomatous changes mimics anaplasia in otherwise grade I meningiomas
26. Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas
27. Reliable Clinical MLH1 Promoter Hypermethylation Assessment Using a High-Throughput Genome-Wide Methylation Array Platform
28. Leveraging archival cerebrospinal fluid samples for genetic insights from cell‐free DNA
29. Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS
30. Clinical Use of Cell-Free DNA in Tumor Diagnostics
31. Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma—Response
32. Data from Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma
33. Supplementary Table S2 from Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma
34. Supplementary Figure S3 from Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma
35. Data from Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors
36. Supplementary Table 2 from Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors
37. Supplementary Table 1 from Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors
38. Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma
39. Malignant transformation of a polymorphous low grade neuroepithelial tumor of the young (PLNTY)
40. Surgical resection of granular cell tumor of the sellar region: three indications
41. Polymorphous low-grade neuroepithelial tumor of the young with FGFR3-TACC3 fusion mimicking high-grade glioma: case report and series of high-grade correlates
42. Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors
43. EPCO-01. THE GENOMIC LANDSCAPE OF BRAIN METASTASIS
44. MODL-37. MODELING REVERSIBLE TUMORIGENESIS IN CEREBRAL ORGANOIDS
45. NIMG-38. TUMOR VOLUME GROWTH RATES AND DOUBLING TIMES DURING ACTIVE SURVEILLANCE OF IDH-MUTANT LOW-GRADE GLIOMA
46. Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions
47. Debio1347, an Oral FGFR Inhibitor: Results From a Single-Center Study in Pediatric Patients With Recurrent or Refractory FGFR-Altered Gliomas
48. Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
49. Treatment and outcomes of IDH1-mutant gliomas in elderly patients
50. Recurrent TRAK1::RAF1 Fusions in pediatric low‐grade gliomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.